The Belgian Health Care Knowledge Center published report for static automated external defibrillators for use by bystanders for out of hospital cardiac arrest

06

Nov 2017

The Belgian Health Care Knowledge Center (KCE) released report of health technology assessment dedicated to static automated external defibrillators (AEDs) for use by bystanders. AEDs are not included into a coordinated public access defibrillation (PAD) programme. The aim of the report was to define if the government should support (also financially) the current practice or not (as currently most AEDs are privately owned). A second object of the assessment concerned the utility of the mandatory central registration of AEDs by the SPF Public Health.

For these purposes, a systematic literature search of health technology assessments and systematic reviews, complemented by search for Belgian data on applications of AEDs was performed. External experts and stakeholders were involved in review process to obtain critical appraisal of the proposed methodology and relevance of the report.

One HTA report that had been published by Ireland’s Health Information and Quality Authority (HIQA) was identified within the search. This report considered only one comparative study of the provision of static AEDs in public locations: the Public Access Defibrillation Trial.

Data on the number of AEDs in Belgium were extracted from the Federal Public Service (FPS) database. For statistics on out of hospital cardiac arrest (OHCA) and potential use of AED, data from the MUGREG/SMUREG registry were analyzed. However, available evidence suffered from severe limitations in relation to quality and completeness.

Additionally, current report contains information about legislation of AEDs and reveals requirements of installation and application of AEDs in Belgium. The current Belgian legislation recommends placing of AEDs in high risk public places.

Given the lack of robust evidence on the effectiveness of AED use by lay bystanders in public locations as well as the lack of robust Belgian data on current AED use, it was not possible to properly evaluate the cost-effectiveness impact of AED provision in Belgium. Therefore, no firm recommendation can be given regarding the provision of static AEDs to be used by bystanders in Belgium. In the same time, KCE suggested to utilize existing registries more efficient. Also, the importance of raising awareness about CPR in public and need of trainings was highlighted as a first step in the utilization of AED.

See full report in English here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

24

Mar 2022

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 2472 of February 10, 2022, Tuscany Regional Healthcare has published assessments of five medical devices of various therapeutic areas, such as cardiovascular and peripheral vascular areas.

Read more

15

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Read more

11

Mar 2022

On February 07, 2022, the Dental and Pharmaceutical Benefits Agency has announced the withdrawal of the assessments of the PhysioMem PM 100 and CardioMem CM 100 XT and the finalization of the assessments of the Zenicor ECG, Coala Heart Monitor Pro, and KardiaMobile. For the conducted assessments, it was outlined that the portable devices provide more limited information than standard ECG measurements; therefore, it was mainly estimated for atrial fibrillation.

Read more

10

Mar 2022

In February 2022, the Finnish Coordinating Center for Health Technology Assessment announced the release of the seven accomplished rapid hospital assessments performed by the Helsinki, Tampere, and Oulu University Hospital. The accomplished rapid HTAs concern the diagnostic imaging, e-Health, endocrine, endoscopy, men’s health, neuromodulation technology groups.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more